Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues:
Total revenues	$ 2,639	$ 374,557	$ 69,393	$ 1,566,387
Operating expenses:
Cost of revenue	38	22,253	1,967	140,323
Research and development	148,253	114,166	477,756	319,475
Selling, general and administrative	41,080	43,174	134,959	123,019
Total operating expenses	189,371	179,593	614,682	582,817
(Loss) income from operations	(186,732)	194,964	(545,289)	983,570
Other income (expense):
Change in fair value of equity investments	(2,707)	(13,590)	(20,896)	(120,019)
Interest income	21,931	9,332	66,254	11,920
Other income (expense), net	882	27,026	(7,506)	30,447
Total other income (expense)	20,106	22,768	37,852	(77,652)
(Loss) income before benefit from (provision for) income taxes	(166,626)	217,732	(507,437)	905,918
Benefit from (provision for) income taxes	3,213	(42,420)	8,293	(288,478)
Net (loss) income	(163,413)	175,312	(499,144)	617,440
Net loss attributable to noncontrolling interest	0	0	(56)	0
Net (loss) income attributable to Vir	$ (163,413)	$ 175,312	$ (499,088)	$ 617,440
Net (loss) income per share, basic (in USD per share)	$ (1.22)	$ 1.32	$ (3.73)	$ 4.66
Net (loss) income per share, diluted (in USD per share)	$ (1.22)	$ 1.30	$ (3.73)	$ 4.58
Weighted-average shares outstanding, basic (in shares)	134,289,620	132,729,530	133,969,878	132,422,028
Weighted-average share outstanding, diluted	134,289,620	134,963,317	133,969,878	134,711,777
Collaboration revenue
Revenues:
Total revenues	$ (4,387)	$ 309,145	$ 28,408	$ 1,483,860
Contract revenue
Revenues:
Total revenues	289	39,998	1,484	52,534
License revenue from a related party
Revenues:
Total revenues	0	22,289	0	22,289
Grant revenue
Revenues:
Total revenues	$ 6,737	$ 3,125	$ 39,501	$ 7,704